The Traderszone Network

Published in TZ Latest News 28 June, 2021 by The TZ Newswire Staff

Why Anavex Life Sciences Shares Are Up 17% Today

Shares of biopharma outfit Anavex Life Sciences (NASDAQ: AVXL) are up 17.2% as of early afternoon following a trial update for its flagship therapy ANAVEX 2-73. The drug, also called blarcamesine, prompted marked improvements in the cognitive capabilities of Parkinson’s disease patients.

read more